Metraipolis › archive › dc_b40c2f2af40a

Effectiveness of SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Integrative Review of Reviews and Comparative Effectiveness Studies (2020-2025) — Europe PMC PMID:41874055

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41874055
DOI
10.3390/pharmacy14020047
License (as archived)
solo-consultazione
Archived
2026-11-04T12:34:41.855Z
SHA-256 of the archived text
6aaf32433f251a0f469a8120bb3d0decd49eb8b24d0665ad068012a1fe8ea680
Stable URL of this page
https://metraipolis.com/documento/dc_b40c2f2af40a

How to cite

Effectiveness of SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Integrative Review of Reviews and Comparative Effectiveness Studies (2020-2025) — Europe PMC PMID:41874055 — Europe PMC (en), https://europepmc.org/article/MED/41874055 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b40c2f2af40a (Metraipolis archive dc_b40c2f2af40a, sha256 6aaf32433f251a0f469a8120bb3d0decd49eb8b24d0665ad068012a1fe8ea680)
BibTeX
@misc{dcb40c2f2af40a,
  title = {Effectiveness of SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Integrative Review of Reviews and Comparative Effectiveness Studies (2020-2025) — Europe PMC PMID:41874055},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41874055},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b40c2f2af40a; sha256 6aaf32433f251a0f469a8120bb3d0decd49eb8b24d0665ad068012a1fe8ea680},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41874055. Agents can read the archived copy with the MCP tool read_document.